Golden
Senti Biosciences

Senti Biosciences

A synthetic biology company that designs, builds and tests genetic circuits for the purposes programming cell therapies. Their first therapeutic candidates are aimed at solid tumors and blood cancer and the company plans to move beyond oncology.

Edit ID  10278144 

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 21 Mar 2019 12:21 am
Edits made to:
Article (+8/-8 characters)

Article

Co-founder and CEO Dr. Tim Lu, (M.D.,Ph.D.) is an Associate Professor at MIT in Biological Engineering, Electrical Engineering and Computer Science and co-founder of SynlogicSynlogic, Tango Therapeutics, Sample6, Eligo BiomX and Engine Biosciences. In Fall 2018, Gary Lee, Ph.D., previously with Sangamo Therapeutics, joined Senti as Chief Scientific Officer. Senti’s Chief Financial Officer Curt Herberts also comes from Sangamo.